CCDC62

Across TCGA pan-cancer cohorts, CCDC62 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of CCDC62’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where CCDC62 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CCDC62 is over-expressed in tumor, although a few such as BRCA and KICH show the opposite, repressed pattern.

STAD, CHOL, and BRCA are the cancer types where CCDC62 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCDC62 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.171	.005	4	view →
CHOL	All	All	+0.171	.001	3	view →
BRCA	All	IV	−0.125	.020	2	view →
KICH	All	All	−0.120	.008	2	view →
KIRC	All	III,IV	−0.046	.028	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

CCDC62–STAD

Open the STAD breakdown →